We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$330M
AUM Growth
+$61.9M
Cap. Flow
+$39.2M
Cap. Flow %
11.89%
Top 10 Hldgs %
62.41%
Holding
32
New
4
Increased
15
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$18.1M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.6M
3
QGEN icon
Qiagen
QGEN
+$6.19M
4
MDT icon
Medtronic
MDT
+$5.89M
5
CVS icon
CVS Health
CVS
+$4.78M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10M
2
ABT icon
Abbott
ABT
+$7.27M
3
AMGN icon
Amgen
AMGN
+$4.58M
4
THC icon
Tenet Healthcare
THC
+$4.01M
5
UHS icon
Universal Health Services
UHS
+$3.74M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$31.1M 9.45%
602,000
+67,000
+13% +$3.14M
MDT icon
2
Medtronic
MDT
$106B
$30.2M 9.15%
334,890
+70,000
+26% +$5.89M
GILD icon
3
Gilead Sciences
GILD
$167B
$24.2M 7.36%
289,163
-131,000
-31% -$10M
PFE icon
4
Pfizer
PFE
$143B
$23.7M 7.2%
820,000
-75,000
-8% -$2.19M
CVS icon
5
CVS Health
CVS
$137B
$19M 5.76%
302,000
+82,000
+37% +$4.78M
BDX icon
6
Becton Dickinson
BDX
$43.6B
$18.6M 5.65%
+77,280
New +$18.1M
INCY icon
7
Incyte
INCY
$23.4B
$17.1M 5.19%
259,000
+55,624
+27% +$3.55M
BAX icon
8
Baxter International
BAX
$11.7B
$14.6M 4.44%
385,000
+125,000
+48% +$4.59M
ELV icon
9
Elevance Health
ELV
$80.9B
$13.7M 4.15%
26,279
+2,000
+8% +$1.07M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.5B
$13.4M 4.06%
190,348
+127,000
+200% +$10.6M
CAH icon
11
Cardinal Health
CAH
$53.5B
$12.9M 3.93%
117,098
+10,000
+9% +$1.05M
ZBH icon
12
Zimmer Biomet
ZBH
$17.6B
$11.4M 3.47%
106,000
+21,000
+25% +$2.29M
BRKR icon
13
Bruker
BRKR
$8.86B
$11M 3.33%
158,970
+43,498
+38% +$2.81M
QGEN icon
14
Qiagen
QGEN
$8.49B
$10.2M 3.09%
216,926
+135,761
+167% +$6.19M
GEHC icon
15
GE HealthCare
GEHC
$28.7B
$10M 3.04%
106,700
+2,700
+3% +$227K
IONS icon
16
Ionis Pharmaceuticals
IONS
$8.99B
$8.45M 2.56%
210,842
+40,842
+24% +$1.9M
CNC icon
17
Centene
CNC
$32.8B
$7.15M 2.17%
95,000
+50,000
+111% +$3.67M
EW icon
18
Edwards Lifesciences
EW
$49.4B
$7.01M 2.13%
106,153
+37,000
+54% +$2.69M
BIIB icon
19
Biogen
BIIB
$30.4B
$6.82M 2.07%
35,166
-8,819
-20% -$1.85M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.15B
$5.63M 1.71%
16,829
– –
AMGN icon
21
Amgen
AMGN
$198B
$5.16M 1.56%
16,000
-14,000
-47% -$4.58M
BNTX icon
22
BioNTech
BNTX
$23.1B
$4.75M 1.44%
+40,000
New +$3.68M
THC icon
23
Tenet Healthcare
THC
$16.8B
$4.38M 1.33%
26,361
-26,500
-50% -$4.01M
UHS icon
24
Universal Health Services
UHS
$9.15B
$4.04M 1.22%
17,627
-17,373
-50% -$3.74M
HUM icon
25
Humana
HUM
$48B
$3.8M 1.15%
+12,000
New +$4.27M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2024 Portfolio in Review

As of Q3 2024, Sector Gamma AS held 32 positions worth $330M, up 23% from $268M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sector Gamma AS deployed $39.2M of net new capital in Q3 2024, opening 4 new positions and adding to 15 existing holdings. Its largest new stake was Becton Dickinson: 77,280 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Gilead Sciences, an estimated $10M trimmed.

  • Sector Gamma AS's largest Q3 2024 buy was Becton Dickinson: 77,280 shares worth $18.6M.
  • Sector Gamma AS added most to BioMarin Pharmaceuticals in Q3 2024, an estimated $10.6M increase.
  • Sector Gamma AS's biggest Q3 2024 reduction was Gilead Sciences, cutting an estimated $10M.
  • Sector Gamma AS fully exited Abbott in Q3 2024, selling an estimated $7.27M.
  • Sector Gamma AS's ten largest holdings make up 62% of its $330M portfolio in Q3 2024.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q3 2024.
  • Sector Gamma AS's portfolio value rose 23% quarter-over-quarter to $330M.

Based on Sector Gamma AS's 13F filing for Q3 2024, filed 13 Nov 2024.